Abbvie (ABBV) PT Raised to $260 at Freedom Capital Markets
Tweet
Share
E-mailGet Alerts ABBV Hot Sheet
Price: $250.82 +0.83%
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Freedom Capital Markets analyst Ilya Zubkov raised the price target on Abbvie (NYSE: ABBV) to $260.00 (from $245.00) while maintaining a Buy rating.
You May Also Be Interested In
- Wolfe Research Upgrades Abbvie (ABBV) to Outperform
- The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For
- Singapore Technologies Engineering (STE:SP) (SGGKF) PT Raised to SGD10.24 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
